LODOSYN 511 Pill - orange round, 8mm
Generic Name: carbidopa
Pill with imprint LODOSYN 511 is Orange, Round and has been identified as Lodosyn 25 mg. It is supplied by Bristol-Myers Squibb.
Lodosyn is used in the treatment of GTP-CH Deficiency; Neuroleptic Malignant Syndrome; Parkinsonian Tremor and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Lodosyn 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LODOSYN 511
Lodosyn
- Generic Name
- carbidopa
- Imprint
- LODOSYN 511
- Strength
- 25 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00056-0511 (Discontinued)
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Rytary
Rytary is used to treat symptoms of Parkinson's disease and parkinsonism that may follow carbon ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Crexont
Crexont (carbidopa and levodopa) is an extended-release capsule that may be used to treat symptoms ...
Sinemet CR
Sinemet CR is used for GTP-CH Deficiency, neuroleptic malignant syndrome, parkinson's disease ...
Duopa
Duopa is used to treat movement problems in people with advanced Parkinson's disease. Learn about ...
Carbidopa/levodopa
Carbidopa/levodopa is used for GTP-CH Deficiency, neuroleptic malignant syndrome, parkinson's ...
More about Lodosyn (carbidopa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: dopaminergic antiparkinsonism agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.